TNF and infection: These results lead to the conclusion that infections were the most frequent AEs but a meta-analysis comparing the safety profile of TCZ with that of other biologics including TNF inhibitors, anakinra (IL-1R antagonist), abatacept, and rituximab showed similar rates of infection [81].